(Q47838423)

English

Uterine artery Doppler and adverse pregnancy outcome in women with extreme levels of fetoplacental proteins used for Down syndrome screening

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/21520313

Uterine artery Doppler and adverse pregnancy outcome in women with extreme levels of fetoplacental proteins used for Down syndrome screening (English)

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/21520313

human pregnancy

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

pregnancy outcome

1 reference

based on heuristic

inferred from title

author name string

E Filippi

1

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/21520313

J Staughton

2

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/21520313

E Peregrine

3

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/21520313

P Jones

4

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/21520313

W Huttly

5

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/21520313

D M Peebles

6

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/21520313

P Pandya

7

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/21520313

A L David

8

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/21520313

publication date

1 May 2011

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/21520313

Ultrasound in Obstetrics and Gynecology

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/21520313

37

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/21520313

5

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/21520313

520-527

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/21520313

Association of extreme first-trimester free human chorionic gonadotropin-beta, pregnancy-associated plasma protein A, and nuchal translucency with intrauterine growth restriction and other adverse pregnancy outcomes.

1 reference

https://api.crossref.org/works/10.1002%2FUOG.8901

21 January 2018

Predicting complications of pregnancy with first-trimester maternal serum free-betahCG, PAPP-A and inhibin-A.

1 reference

https://api.crossref.org/works/10.1002%2FUOG.8901

21 January 2018

First-trimester maternal serum PAPP-A and free-beta subunit human chorionic gonadotropin concentrations and nuchal translucency are associated with obstetric complications: a population-based screening study (the FASTER Trial).

1 reference

https://api.crossref.org/works/10.1002%2FUOG.8901

21 January 2018

World Health Organization systematic review of screening tests for preeclampsia

1 reference

https://api.crossref.org/works/10.1002%2FUOG.8901

21 January 2018

Screening in early pregnancy for pre-eclampsia using Down syndrome quadruple test markers

1 reference

https://api.crossref.org/works/10.1002%2FUOG.8901

21 January 2018

Quad screen as a predictor of adverse pregnancy outcome

1 reference

https://api.crossref.org/works/10.1002%2FUOG.8901

21 January 2018

The role of uterine artery Doppler in predicting adverse pregnancy outcome

1 reference

https://api.crossref.org/works/10.1002%2FUOG.8901

21 January 2018

Use of uterine artery Doppler ultrasonography to predict pre-eclampsia and intrauterine growth restriction: a systematic review and bivariable meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2FUOG.8901

21 January 2018

Prediction of pre-eclampsia by uterine artery Doppler ultrasonography and maternal serum pregnancy-associated plasma protein-A, free beta-human chorionic gonadotropin, activin A and inhibin A at 22 + 0 to 24 + 6 weeks' gestation

1 reference

https://api.crossref.org/works/10.1002%2FUOG.8901

21 January 2018

Uterine artery Doppler velocimetry in the detection of adverse obstetric outcomes in women with unexplained elevated maternal serum alpha-fetoprotein levels.

1 reference

https://api.crossref.org/works/10.1002%2FUOG.8901

21 January 2018

The predictive value of 18 and 22 week uterine artery Doppler in patients with low first trimester maternal serum PAPP-A.

1 reference

https://api.crossref.org/works/10.1002%2FUOG.8901

21 January 2018

The clinical value of combining maternal serum screening and uterine artery Doppler in prediction of adverse pregnancy outcome.

1 reference

https://api.crossref.org/works/10.1002%2FUOG.8901

21 January 2018

Improved early prediction of pre-eclampsia by combining second-trimester maternal serum inhibin-A and uterine artery Doppler.

1 reference

https://api.crossref.org/works/10.1002%2FUOG.8901

21 January 2018

Abnormal multiple marker screens are associated with adverse perinatal outcomes in cases of intrauterine growth restriction

1 reference

https://api.crossref.org/works/10.1002%2FUOG.8901

21 January 2018

Mid-trimester uterine artery Doppler screening as a predictor of adverse pregnancy outcome in high-risk women.

1 reference

https://api.crossref.org/works/10.1002%2FUOG.8901

21 January 2018

Placental size and the prediction of severe early-onset intrauterine growth restriction in women with low pregnancy-associated plasma protein-A.

1 reference

https://api.crossref.org/works/10.1002%2FUOG.8901

21 January 2018

Obstetrical complications associated with abnormal maternal serum markers analytes

1 reference

https://api.crossref.org/works/10.1002%2FUOG.8901

21 January 2018

Practical issues drawn from the implementation of the integrated test for Down syndrome screening into routine clinical practice

1 reference

https://api.crossref.org/works/10.1002%2FUOG.8901

21 January 2018

Identifiers

10.1002/UOG.8901

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/21520313

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/21520313

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47838423&oldid=2172500463"